Senior insider sale
Chief Scientific Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$132.3K
4.90K shares
What this filing means
LILLIE JAMES WOODRUFF plans to sell 4.90K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $132.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/15/2026ACC: 0001974158-26-000047
Officer· Chief Scientific Officer
Since Feb 2026
4.90K
Shares to sell
$132.3K
Approx. market value
10.78K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock Unit Grant
N/A
5/2/2024
6.15KRestricted Stock Unit Grant
N/A
11/9/2023
1.43KRestricted Stock Unit Grant
N/A
7/30/2023
3.20KTotal acquired10.78K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/2/2024 | Restricted Stock Unit Grant N/A | 6.15K | — |
11/9/2023 | Restricted Stock Unit Grant N/A | 1.43K | — |
7/30/2023 | Restricted Stock Unit Grant N/A | 3.20K | — |
| Total | 10.78K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.90K
Market value
$132.3K
4/15/2026
Total
Units
4.90K
Value
$132.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/15/2026 | 4.90K | $132.3K | NASDAQ | Planned |
| Total | 4.90K | $132.3K | ||